C48H44N6O6
Neat
800.92
144690-92-6; Tritylolmesartan medoxomil; Trityl olmesartan; N1-Tritylolmesartan medoxomil; UNII-8591TIT360; 8591TIT360; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1, 1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1, 3-dioxol-4-yl)methyl ester; DTXSID70162785; EC 604-437-3; (5-Methyl-2-oxo-1, 3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1, 1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1, 3-dioxol-4-yl)methyl ester; (5-methyl-2-oxo-1, 3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate; Olmesartan medoxomil impurity, N-alkyl impurity-(USP); Olmesartan medoxomil impurity, N-alkyl impurity-[USP]; OLMESARTAN MEDOXOMIL IMPURITY, N-ALKYL IMPURITY-(USP IMPURITY); OLMESARTAN MEDOXOMIL IMPURITY and N-ALKYL IMPURITY-[USP IMPURITY]; RefChem:192216; DTXCID2085276; 604-437-3; Triphenyl methyl olmesartan
(5-methyl-2-oxo-1 and 3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
InChI=1S/C48H44N6O6/c1-5-17-41-49-43(47(3,4)57)42(45(55)58-31-40-32(2)59-46(56)60-40)53(41)30-33-26-28-34(29-27-33)38-24-15-16-25-39(38)44-50-51-52-54(44)48(35-18-9-6-10-19-35,36-20-11-7-12-21-36)37-22-13-8-14-23-37/h6-16,18-29,57H,5,17,30-31H2,1-4H3